The PROcedure Rehearsal Studio(TM), Simbionix' latest innovative medical simulation system, is the world's first medical simulator that enables clinicians to create practice scenarios based on their patient's unique pathology and anatomy.
Dr. Karl Illig, Chief of Vascular Surgery at Strong Medical Center in Rochester, NY, explains why physicians are eager to start using the new simulator: "PROcedure Studio helps us identify pitfalls and problems and solve them on the machine. If we're going to make a mistake, let's make it on the simulators first."
Gary Zamler, CEO of Simbionix, sees the launch of Procedure as "a quantum leap in the world of medical simulation that has the potential to significantly improve patient outcomes while reducing health care costs."
"Our leading technology has made Simbionix the industry leader in medical simulation. PROcedure Rehearsal Studio shows where that leadership will be taking everyone."
Mr. Zamler also announced that Strong Medical Center in Rochester, NY, Imperial College, UK, and Sheba Hospital, Israel have already signed agreements with Simbionix to use PROcedure Rehearsal Studio in their simulation centers.
"These leading hospitals will use and test PROcedure Rehearsal Studio in accordance with Simbionix' philosophy and mission to collaborate with the medical community developing leading-edge technologies for training and education while promoting patient safety."
Simbionix will unveil this next generation of medical simulation on October 12th at the Annual Transcatheter Cardiovascular Therapeutic symposium (TCT) in Washington, DC.
Simbionix is a global leader in medical simulation technology. Simbionix mission is to provide state of the art, computer-assisted metrics-based surgical simulation systems, and set the standard for minimally invasive surgical training and performance.
Simbionix products provide medical experts with hands-on training in a comprehensive array of MIS procedures, including; GI Endoscopy, Endourology, percutaneous access, advanced laparoscopic procedures and Endovascular procedures.
http://www.simbionix.com Contact: Inbal Mazor VP Marketing Simbionix email@example.com Tel: +972-8-9211177